Ubs Asset Management Americas Inc Aurinia Pharmaceuticals Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 298,454 shares of AUPH stock, worth $2.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
298,454
Previous 325,882 8.42%
Holding current value
$2.42 Million
Previous $1.86 Million 17.58%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.32 - $7.33 $145,916 - $201,047
-27,428 Reduced 8.42%
298,454 $2.19 Million
Q2 2024

Aug 13, 2024
BUY
$4.81 - $5.78 $797,180 - $957,942
165,734 Added 103.49%
325,882 $1.86 Million
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $88,747 - $118,122
12,447 Added 8.43%
160,148 $1.44 Million
Q3 2023

Nov 13, 2023
SELL
$7.77 - $12.27 $7,420 - $11,717
-955 Reduced 0.64%
147,701 $1.15 Million
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $37,285 - $70,741
6,277 Added 4.41%
148,656 $1.63 Million
Q4 2022

Feb 14, 2023
BUY
$4.11 - $8.14 $211,948 - $419,771
51,569 Added 56.79%
142,379 $615,000
Q3 2022

Nov 14, 2022
SELL
$6.66 - $12.39 $60,139 - $111,881
-9,030 Reduced 9.04%
90,810 $682,000
Q2 2022

Aug 12, 2022
BUY
$8.95 - $12.8 $421,544 - $602,880
47,100 Added 89.31%
99,840 $1 Million
Q1 2022

May 16, 2022
SELL
$10.05 - $22.48 $891,625 - $1.99 Million
-88,719 Reduced 62.72%
52,740 $652,000
Q4 2021

Feb 14, 2022
BUY
$17.78 - $33.08 $2.3 Million - $4.27 Million
129,178 Added 1051.85%
141,459 $3.24 Million
Q3 2021

Nov 15, 2021
SELL
$10.93 - $23.55 $1.41 Million - $3.04 Million
-129,178 Reduced 91.32%
12,281 $271,000
Q2 2021

Aug 16, 2021
BUY
$10.0 - $14.52 $213,000 - $309,276
21,300 Added 17.73%
141,459 $1.83 Million
Q1 2021

May 14, 2021
BUY
$12.3 - $18.73 $100,860 - $153,586
8,200 Added 7.32%
120,159 $1.56 Million
Q4 2020

Mar 01, 2021
BUY
$12.94 - $16.05 $164,338 - $203,835
12,700 Added 12.79%
111,959 $1.55 Million
Q3 2020

Nov 13, 2020
BUY
$13.19 - $16.66 $262,481 - $331,534
19,900 Added 25.08%
99,259 $1.46 Million
Q2 2020

Aug 14, 2020
BUY
$14.12 - $18.33 $83,308 - $108,146
5,900 Added 8.03%
79,359 $1.29 Million
Q1 2020

May 15, 2020
BUY
$11.34 - $21.46 $206,388 - $390,572
18,200 Added 32.94%
73,459 $1.07 Million
Q4 2019

Feb 14, 2020
BUY
$3.88 - $21.42 $150,544 - $831,096
38,800 Added 235.74%
55,259 $1.12 Million
Q3 2019

Nov 14, 2019
BUY
$5.34 - $6.59 $16,869 - $20,817
3,159 Added 23.75%
16,459 $87,000
Q2 2019

Aug 15, 2019
BUY
$6.05 - $6.75 $80,465 - $89,775
13,300 New
13,300 $0

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email